CureDuchenne hosts webinars with pharmaceutical, biotech and researchers focused on Duchenne muscular dystrophy.

CureDuchenne Webinar with Avidity Biosciences

CureDuchenne Webinar with Avidity Biosciences, a privately held biotech company pioneering a new class of precision medicines based upon antibody-oligonucleotide conjugates, to brief the Duchenne community about Avidity’s research in […]

Update on Santhera, Idbenone in DMD and SIDEROS Trial

This webinar provided an update from Santhera Pharmaceuticals about the SIDEROS trial of idebenone in boys taking steroids. Santhera also provided an update about their regulatory efforts to bring this treatment to boys with Duchenne in the US and Europe.